作者:Mark C. Elliott、David E. Hibbs、David S. Hughes、Michael B. Hursthouse、Elbertus Kruiswijk、K. M. Abdul Malik
DOI:10.1023/a:1021791832534
日期:——
Three novel dihydropyrimidine compounds N8,6-di(4-nitrophenyl)-(3R)-ethyl-(7R)-methyl-5-oxo-2,3,6,7-tetrahydrooxazolo[3,2,c] pyrimidine-8-carboxamide (2), N8,6-di((4-methylphenyl)sulfonyl)-(3R)-ethyl-5-oxo-(7R)-phenyl-2,3,6,7-tetrahydrooxazolo [3,2,c]pyrimidine-8-carboxamide (3) and N8,6-di ((4-methylphenyl)sulfonyl)-(3R)-ethyl-(7R)-methyl-5-oxo-2,3,6,7- tetrahydrooxazolo[3.2,c] pyrimidine-8-carboxamide (4) have been prepared (from 2-amino-1-butanol of 64.4% e.e.) and structurally characterized by X-ray crystallography. All three compounds contain stereogenic centers, but the crystal of (2) chosen was found to be racemic whilst those of (3) and (4) were found to be homochiral. Compound (2) crystallizes in the monoclinic space group P2(1)/c, with a = 17.958(4), b = 12.431(2), c = 9.653(2) Angstrom, beta = 96.20(3)degrees, U = 2142.3(7) Angstrom(3), Z = 4, and D-c = 1.449 g cm(-3). Compounds (3) and (4) both crystallize in the monoclinic space group P2(1), with a = 9.349(2), b = 5.824(5), c = 26.513(8) Angstrom, beta = 99.43(2)degrees, U = 1424.1(13) Angstrom(3), Z = 2 and D-c = 1.389 g cm(-3) for (3), and a = 5.9526(9), b = 16.3521(10), c = 13.2263(11) Angstrom, beta = 92.81(12)degrees, U = 1285.9(2) Angstrom(3), Z = 2 and D-c = 1.378 g cm(-3) for (4).